NaV1.7 - "Pharmacology on rNaV1.7 performed on Nanion‘s SyncroPatch 96"
SyncroPatch 96 application note, (a predecessor model of the SyncroPatch 384PE) (0.6 MB)
Cells were kindly provided by Millipore.
NaV1.7 is an increasingly interesting target for drug development due to its role in pain. In this Application Note measurements are presented to demonstrate the accuracy and robustness of pharmacological NaV1.7 data that can be generated with Nanion’s SyncroPatch 96.